Insiders · NRXP

Aaron Gorovitz

Director at NRX Pharmaceuticals, Inc. (NRXP) since May 2021

Aaron Gorovitz has filed 4 insider reports with the SEC since June 2021, as director at NRX Pharmaceuticals, Inc. (NRXP). Aaron Gorovitz made no open-market purchases or sales in the last 12 months. In the latest filing, on September 11, 2023, Aaron Gorovitz bought 35,000 shares of NRX Pharmaceuticals, Inc. (NRXP) for $11.2K at an average of $0.32.

Filings
4
Companies
1
Bought on market
$11.2K
Sold on market
None

Companies where Aaron Gorovitz is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
NRX Pharmaceuticals, Inc. logo
NRXP
NRX Pharmaceuticals, Inc.
Directorsince May 2021$11.2K$0.32$2.15+572%Sep 11, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare Aaron Gorovitz with

Other insiders at the same companies

Questions about Aaron Gorovitz

What is Aaron Gorovitz's role at NRX Pharmaceuticals, Inc.?
Aaron Gorovitz reports to the SEC as director at NRX Pharmaceuticals, Inc. (NRXP), according to the latest filing on September 11, 2023.
Has Aaron Gorovitz bought or sold stock recently?
The most recent open-market purchase was on August 30, 2023: bought 35,000 shares of NRX Pharmaceuticals, Inc. (NRXP) for $11.2K at an average of $0.32.
How do I get alerts when Aaron Gorovitz files?
Follow Aaron Gorovitz on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Aaron Gorovitz (SEC CIK 0001864536). Totals count each trade once, skipping amendments whose original is on file, from Jun 10, 2021 on. View on SEC EDGAR · Get this as JSON